Prussian Blue Nanozyme Normalizes Microenvironment to Delay Osteoporosis (Adv. Healthcare Mater. 19/2022). Issue 19 (5th October 2022)

• Record Type: Journal Article
• Authors: Ye, Chenyi; Zhang, Wei; Zhao, Yongzheng; Zhang, Kai; Hou, Weiduo; Chen, Mo; Lu, Jinwei; Wu, Jianrong; He, Rongxin; Gao, Wei; Zheng, Yuanyi; Cai, Xiaojun
• Is Part Of: Advanced healthcare materials. Volume 11:Issue 19(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-10-05
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/adhm.202270118
• Languages: English
• ISSNs: 2192-2640

Abstract

Abstract : Prussian Blue Nanoenzymes In article 2200787 by Rongxin He, Wei Gao, Xiaojun Cai and co‐workers, hollow Prussian blue nanozymes (HPBZs) significantly normalize the osteoporosis microenvironment, thereby inhibiting osteoclast formation and osteoclast resorption for treatment of osteoporosis, possibly owing to the suppression of the mitogen‐activated protein kinase and nuclear factor κ B signaling pathways.